190 related articles for article (PubMed ID: 2842263)
1. Relationship between inhibition of erythrocyte pyrimidine 5'-nucleotidase activity and biological response for porphyrin metabolism in workers occupationally exposed to lead.
Tomokuni K; Ichiba M; Hirai Y; Hasegawa T; Sugimoto K
Int Arch Occup Environ Health; 1988; 60(6):431-6. PubMed ID: 2842263
[TBL] [Abstract][Full Text] [Related]
2. Studies on erythrocyte pyrimidine 5'-nucleotidase (P5N) test and its evaluation in workers occupationally exposed to lead.
Ichiba M; Tomokuni K
Int Arch Occup Environ Health; 1990; 62(4):305-10. PubMed ID: 2379961
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of lead exposure in workers at a lead-acid battery factory in Korea: with focus on activity of erythrocyte pyrimidine 5'-nucleotidase (P5N).
Kim Y; Harada K; Ohmori S; Lee BK; Miura H; Ueda A
Occup Environ Med; 1995 Jul; 52(7):484-8. PubMed ID: 7670624
[TBL] [Abstract][Full Text] [Related]
4. Effect of lead exposure on some biological indices related to porphyrin metabolism and the activity of erythrocyte pyrimidine 5'-nucleotidase in the mice.
Tomokuni K; Ichiba M; Hirai Y
Arch Toxicol; 1989; 63(1):23-8. PubMed ID: 2545181
[TBL] [Abstract][Full Text] [Related]
5. A simplified method for determining erythrocyte pyrimidine 5'-nucleotidase (P5N) activity by HPLC and its value in monitoring lead exposure.
Sakai T; Ushio K
Br J Ind Med; 1986 Dec; 43(12):839-44. PubMed ID: 3026435
[TBL] [Abstract][Full Text] [Related]
6. Erythrocyte pyrimidine 5'-nucleotidase activity in workers exposed to lead, mercury or cadmium.
Mohammed-Brahim B; Buchet JP; Lauwerys R
Int Arch Occup Environ Health; 1985; 55(3):247-52. PubMed ID: 2987134
[TBL] [Abstract][Full Text] [Related]
7. Erythrocyte arginase, pyrimidine 5'-nucleotidase (P5N), and deoxypyrimidine 5'-nucleotidase (dP5N) as indices of lead exposure.
Cook LR; Angle CR; Stohs SJ
Br J Ind Med; 1986 Jun; 43(6):387-90. PubMed ID: 3013277
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of lead exposure in workers at secondary lead smelters in South Korea: with focus on activity of erythrocyte pyrimidine 5'-nucleotidase (P5N).
Kim Y; Lee H; Lee CR; Park DU; Yang JS; Park IJ; Lee KY; Lee M; Kim TK; Sohn NS; Cho YS; Lee N; Chung HK
Sci Total Environ; 2002 Mar; 286(1-3):181-9. PubMed ID: 11886093
[TBL] [Abstract][Full Text] [Related]
9. Comparison of inhibition of erythrocyte pyrimidine 5'-nucleotidase and delta-aminolevulinic acid dehydratase by lead.
Tomokuni K; Ichiba M
Toxicol Lett; 1988 Feb; 40(2):159-63. PubMed ID: 2829393
[TBL] [Abstract][Full Text] [Related]
10. Prediction of blood lead by HPLC assay of erythrocyte pyrimidine 5'-nucleotidase.
Cook LR; Angle CR; Kubitschek CE; Stohs SJ
J Anal Toxicol; 1987; 11(1):39-42. PubMed ID: 3029506
[TBL] [Abstract][Full Text] [Related]
11. [Reviews on biochemical markers of lead exposure with special emphasis on heme and nucleotide metabolisms].
Sakai T
Sangyo Eiseigaku Zasshi; 1995 Mar; 37(2):99-112. PubMed ID: 7749999
[TBL] [Abstract][Full Text] [Related]
12. Relationship between lead concentration in blood and biological response for porphyrin metabolism in workers occupationally exposed to lead.
Tomokuni K; Ogata M
Arch Toxicol; 1976 Aug; 35(4):239-46. PubMed ID: 989294
[TBL] [Abstract][Full Text] [Related]
13. Determination of pyrimidine 5'-nucleotidase (P5N) activity in whole blood as an index of lead exposure.
Sakai T; Araki T; Ushio K
Br J Ind Med; 1988 Jun; 45(6):420-5. PubMed ID: 2840110
[TBL] [Abstract][Full Text] [Related]
14. [Relationship between activity of erythrocyte pyrimidine 5'-nucleotidase (P5N) and concentration of magnesium or zinc in blood in workers exposed to lead].
Ichiba M; Tomokuni K
Sangyo Igaku; 1988 Sep; 30(5):408-9. PubMed ID: 2849695
[No Abstract] [Full Text] [Related]
15. The in vitro and in vivo effects of lead on delta-aminolevulinic acid dehydratase and pyrimidine 5'-nucleotidase.
Ong CN; Kong YM; Ong HY; Teramoto K
Pharmacol Toxicol; 1990 Jan; 66(1):23-6. PubMed ID: 2308903
[TBL] [Abstract][Full Text] [Related]
16. Erythrocyte nucleotides in lead workers.
Ichiba M; Tomokuni K; Mori K
Int Arch Occup Environ Health; 1992; 63(6):419-21. PubMed ID: 1544691
[TBL] [Abstract][Full Text] [Related]
17. Response of erythrocyte pyrimidine 5'-nucleotidase (P5N) activity in workers exposed to lead.
Ichiba M; Tomokuni K
Br J Ind Med; 1988 Oct; 45(10):718-9. PubMed ID: 2848571
[No Abstract] [Full Text] [Related]
18. Evaluation of activity of erythrocyte pyrimidine 5'-nucleotidase (P5N) in lead exposed workers: with focus on the effect on hemoglobin.
Kim Y; Yoo CI; Lee CR; Lee JH; Lee H; Kim SR; Chang SH; Lee WJ; Hwang CH; Lee YH
Ind Health; 2002 Jan; 40(1):23-7. PubMed ID: 11926511
[TBL] [Abstract][Full Text] [Related]
19. Erythrocyte pyrimidine 5'-nucleotidase inhibition by acute lead exposure in neonatal rats.
Konantakieti C; Beuthin FC; Louis-Ferdinand RT
J Biochem Toxicol; 1986 Sep; 1(3):51-9. PubMed ID: 2856073
[TBL] [Abstract][Full Text] [Related]
20. HPLC analysis of erythrocyte pyrimidine-5'-nucleotidase inhibition by lead.
Rocco RM; Smart JL; Brown DR; Blumberg JB
Res Commun Chem Pathol Pharmacol; 1981 Oct; 34(1):127-36. PubMed ID: 6273981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
